|
08:30 Facility based patient and program monitoring approach for
reducing burden of CVD and hypertention
Farzadfar F. (WHO) |
|||
|
08:45 Causality in cardiovascular research
Motevalian A. (Iran) |
|||
|
09:00 Bioprinting application in cardiovascular medicine: achievements
and challenges
Abolfathi N. (Iran) |
|||
|
09:15 Research from scientometric to impact
Akhunzadeh S. (Iran) |
|||
|
09:30 Iranian Registry of Atrial Fibrillation: Second national report
Haghjoo M. (Iran) |
|||
|
09:35 Impact of opium consumption on mid-term outcomes of surgical
revascularization: should we be afraid of quitting?
Masoudkabir F. (Iran) |
|||
|
09:40 INSPIRATION Trial
Sadeghipour P. (Iran) |
|||
|
09:45 Isfahan Healthy Heart Program (IHHP): A successful model for the
prevention and control of Cardiovascular Diseases in low and
middle income countries.
Sarrafzadegan N. (Iran) |
